BZPEERPapers, people, evidence and research paths
Menu

Discover

SearchFind papers, people, topics, institutions and opportunities from one place.GraphSee how papers, authors, topics and evidence connect.

Research tools

HomeContinue from the papers, people and topics that matter now.CollectionsTurn saved papers into reading lists, evidence maps and shareable context.ResearchReconstruct the path that led you from search to paper to question.CollaborationMove from a paper, topic or expert request into a focused thread.PublishCreate full-text research articles with metadata, formulas and versions.

Network

ExpertsFind specialists whose work and reviews explain why they can help.CommunitiesJoin research groups organized around papers, topics and shared evidence.

Opportunities

ListingsBrowse roles, calls and collaborations connected to real research context.

Account

Log inReturn to your saved papers, graph views and active threads.Create accountStart saving papers, building a research trail and joining teams.
Log inCreate account

Source author record

Alex Zhavoronkov

Alex Zhavoronkov appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record
Artificial IntelligenceBiomoleculesDatabasesDigital LibrariesInformation RetrievalMachine LearningMolecular NetworksNeurons and Cognition

Catalog footprint

What is connected

3works
8topics
4close collaborators

Actions

Connect this record

Log in to claim
Open graphBrowse works

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2022arXiv

AlphaFold Accelerates Artificial Intelligence Powered Drug Discovery: Efficient Discovery of a Novel Cyclin-dependent Kinase 20 (CDK20) Small Molecule Inhibitor

The AlphaFold computer program predicted protein structures for the whole human genome, which has been considered as a remarkable breakthrough both in artificial intelligence (AI) application and structural biology. Despite the varying confidence level, these predicted structures still could significantly contribute to structure-based drug design of novel targets, especially the ones with no or limited structural information. In this work, we successfully applied AlphaFold in our end-to-end AI-powered drug discovery engines constituted of a biocomputational platform PandaOmics and a generative chemistry platform Chemistry42, to identify a first-in-class hit molecule of a novel target without an experimental structure starting from target selection towards hit identification in a cost- and time-efficient manner. PandaOmics provided the targets of interest and Chemistry42 generated the molecules based on the AlphaFold predicted structure, and the selected molecules were synthesized and tested in biological assays. Through this approach, we identified a small molecule hit compound for CDK20 with a Kd value of 8.9 +/- 1.6 uM (n = 4) within 30 days from target selection and after only synthesizing 7 compounds. Based on the available data, the second round of AI-powered compound generation was conducted and through which, a more potent hit molecule, ISM042-2 048, was discovered with a Kd value of 210.0 +/- 42.4 nM (n = 2), within 30 days and after synthesizing 6 compounds from the discovery of the first hit ISM042-2-001. To the best of our knowledge, this is the first reported small molecule targeting CDK20 and more importantly, this work is the first demonstration of AlphaFold application in the hit identification process in early drug discovery.

0 citations0 reviewsNo code linkedOpen access
preprint2015arXiv

GrantMed: a new, international system for tracking grants and funding trends in the life sciences

Despite the success of PubMed and other search engines in managing the massive volume of biomedical literature and the retrieval of individual publications, grant-related data remains scattered and relatively inaccessible. This is problematic, as project and funding data has significant analytical value and could be integral to publication retrieval. Here, we introduce GrantMed, a searchable international database of biomedical grants that integrates some 20 million publications with the nearly 1.4 million research projects and 650 billion dollars of funding that made them possible. For any given topic in the life sciences, Grantmed provides instantaneous visualization of the past 30 years of dollars spent and projects awarded, along with detailed individual project descriptions, funding amounts, and links to investigators, research organizations, and resulting publications. It summarizes trends in funding and publication rates for areas of interest and merges data from various national grant databases to create one international grant tracking system. This information will benefit the research community and funding entities alike. Users can view trends over time or current projects underway and use this information to navigate the decision-making process in moving forward. They can view projects prior to publication and records of previous projects. Convenient access to this data for analytical purposes will be beneficial in many ways, helping to prevent project overlap, reduce funding redundancy, identify areas of success, accelerate dissemination of ideas, and expose knowledge gaps in moving forward. It is our hope that this will be a central resource for international life sciences research communities and the funding organizations that support them, ultimately streamlining progress.

0 citations0 reviewsNo code linkedOpen access
preprint2015arXiv

Models of Innate Neural Attractors and Their Applications for Neural Information Processing

In this work we reveal and explore a new class of attractor neural networks, based on inborn connections provided by model molecular markers, the molecular marker based attractor neural networks (MMBANN). We have explored conditions for the existence of attractor states, critical relations between their parameters and the spectrum of single neuron models, which can implement the MMBANN. Besides, we describe functional models (perceptron and SOM) which obtain significant advantages, while using MMBANN. In particular, the perceptron based on MMBANN, gets specificity gain in orders of error probabilities values, MMBANN SOM obtains real neurophysiological meaning, the number of possible grandma cells increases 1000- fold with MMBANN. Each set of markers has a metric, which is used to make connections between neurons containing the markers. The resulting neural networks have sets of attractor states, which can serve as finite grids for representation of variables in computations. These grids may show dimensions of d = 0, 1, 2,... We work with static and dynamic attractor neural networks of dimensions d = 0 and d = 1. We also argue that the number of dimensions which can be represented by attractors of activities of neural networks with the number of elements N=104 does not exceed 8.

0 citations0 reviewsNo code linkedOpen access